Lead and Hypertension: Could a Chelator be the Antihypertensive of Choice?

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.16, Iss.3, 2009-09, pp. : 83-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

β-Blockers and Diuretics in the Treatment of Hypertension: `A Friendly Fire?'

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 3, 2008-01 ,pp. : 109-111

Adis International

Access to resources Recommend Favorite

Is Endothelial Dysfunction a Measurable Endpoint in Hypertension?

By Taddei S. Virdis A. Ghiadoni L. Versari D. Salvetti A.

High Blood Pressure & Cardiovascular Prevention, Vol. 10, Iss. 1, 2003-01 ,pp. : 19-25

Adis International

Access to resources Recommend Favorite

How useful are hypertension guidelines for diabetes?

By Nilsson Peter M

Diabetes Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 115-121

Future Medicine

Access to resources Recommend Favorite

Treatment of Hypertension: Is the Gap between Objectives and Outcomes Insurmountable?

By Volpe M.

High Blood Pressure & Cardiovascular Prevention, Vol. 10, Iss. 1, 2003-01 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

Can the effectiveness of hypertension management be improved?

By Ruilope Luis M

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 689-695

Informa Healthcare

Access to resources Recommend Favorite